Market Place
Sourcing Support
MSN`s Generic Carfilzomib Receives Approval in the U.S.
30 Jan 2023 //
FDA
Eugia`s Generic Carfilzomib Receives Approval in the U.S.
25 Nov 2022 //
FDA
Sanofi reports positive Phase III multiple myeloma trial results
16 May 2022 //
CLINICALTRIALSARENA
FDA Grants Approval to Janssen`s DARZALEX FASPRO + Carfilzomib & Dexamethasone
01 Dec 2021 //
PRNEWSWIRE
Health Canada approves Sanofi`s Sarclisa combination for multiple myeloma
13 Oct 2021 //
SEEKINGALPHA
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
BIOSPACE
NATCO receives approval for Carfilzomib Vials ANDA
14 Jun 2021 //
BUSINESS STANDARD
EC approves new Sarclisa indication
19 Apr 2021 //
PHARMATIMES
NICE recommends Kyprolis triple combination treatment for multiple myeloma
22 Mar 2021 //
PHARMATIMES
New Treatment Regimen Available for KYPROLIS® for Intravenous Injection
27 Nov 2020 //
PRESS RELEASE
FDA Roundup: Kyprolis, Kesimpta, Cystadrops
26 Aug 2020 //
RAPS
J&J adds yet another multiple myeloma regimen to the Darzalex label
21 Aug 2020 //
ENDPOINTSNEWS
US expand use of Janssen`s Darzalex
21 Aug 2020 //
PHARMATIMES
Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX®
20 Aug 2020 //
PRESS RELEASE
Sarclisa® (isatuximab) combination therapy demonstrated superior progression
02 Jun 2020 //
PRESS RELEASE
Oncolytics Biotech® Presents Clinical Proof-of-Concept Data ASCO
29 May 2020 //
ONCOLYTICSBIOTECH
Oncolytics Biotech® Announces Publication of Abstracts at the 2020
13 May 2020 //
PRNEWSWIRE
Sanofi takes aim at J&J`s Darzalex with Sarclisa myeloma win
13 May 2020 //
FIERCE PHARMA
US District Court upheld validity claims of 3 patents protect Amgen`s myeloma
06 May 2020 //
PHARMABIZ
Amgen Wins Ruling on Patents for Kyprolis Cancer Drug
05 May 2020 //
BLOOMBERG
Apotex`s Generic Carfilzomib Receive Approval in U.S
30 Mar 2020 //
FDA
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology in China
03 Jan 2020 //
PRESS RELEASE
Amgen teams up with BeiGene in cancer a $2.7B stake
01 Nov 2019 //
ENDPTS
Amgen`s Kyprolis, J&J`s Darzalex team up on myeloma surviva
17 Sep 2019 //
FIERCE PHARMA
Amgen shares hit after buried FDA trial halt revealed
13 Sep 2019 //
FIERCE BIOTECH
Amgen Phase 3 CANDOR Study of KYPROLIS,DARZALEX meets Primary Progression
13 Sep 2019 //
PR NEWSWIRE
Carfilzomib (Kyprolis): reminder of risk of potentially fatal cardiac events
19 Aug 2019 //
GOVUK
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Karyopharm’s Xpovio nabs myeloma nod despite checkered past. But 5th line?
08 Jul 2019 //
FIERCE PHARMA
Sanofi`s anti-CD38 combo boosts responses
03 Jun 2019 //
FIERCE BIOTECH
Natco, Onyx settle cancer drug patent litigation
01 Jun 2019 //
ECONOMIC TIMES
Amgen rep exodus sparks legal battle with rival Karyopharm
25 May 2019 //
FIERCE PHARMA
List of Paragraph IV Patent Certifications as of Dec 18, 2018
22 Dec 2018 //
FDA
Amgen`s Kyprolis (carfilzomib) Labelling Update From EMA
20 Oct 2018 //
EMA
Could Amgen soften the biosim blow with an Alexion buy?
16 Jul 2018 //
FIERCE PHARMA
FDA Approves Addition Of +ve Overall Survival Data From Ph3 Trial To KYPROLIS®
11 Jun 2018 //
PR NEWSWIRE
Ph3 KYPROLIS® (carfilzomib) Regimen In Patients With R/R Multiple Myeloma
01 Jun 2018 //
PR NEWSWIRE
Amgen Receives +ve CHMP Opinion To Add Survival Results Ph3 ASPIRE KYPROLIS®
30 Apr 2018 //
PR NEWSWIRE
Kyprolis® (Carfilzomib) : Onyx Therapeutics v. Cipla Limited
20 Apr 2018 //
PATENT LITIGATION
Kyprolis® (Carfilzomib):Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical
16 Feb 2018 //
PATENT LITIGATION
Amgen set for Kyprolis label boost after CHMP backing
01 Feb 2018 //
PMLIVE
Amgen Receives CHMP +ve Opinion Updated Overall Survival Data To KYPROLIS® Label
30 Jan 2018 //
PR NEWSWIRE
Kyprolis® (Carfilzomib) : Onyx Therapeutics V. Apotex
24 Jan 2018 //
PATENT LITIGATION
Amgen kicks off 2018 with good news for slow-growing Kyprolis
18 Jan 2018 //
FIERCE PHARMA
Carfilzomib linked to higher rates of cardiovascular problems
04 Jan 2018 //
CEN
Amgen`s Kyprolis improves overall survival in blood cancer patients
13 Dec 2017 //
REUTERS
Amgen hopes its latest Kyprolis trial hits the mark with regulators
26 Oct 2017 //
PMLIVE
Impax Announces FDA Approval and Launch of Generic Renvela Sevelamer Carbonate
23 Oct 2017 //
PR NEWSWIRE
Overall Survival Analysis From KYPROLIS® (carfilzomib) Ph3 Endeavor
23 Aug 2017 //
PR NEWSWIRE
SMC gives green light for Amgen’s Kyprolis
09 Aug 2017 //
PMLIVE
SMC recommends three new medicines
07 Aug 2017 //
PHARMA TIMES
Kezar adds $50M to its funding tally for immunoproteasome drug
26 Jul 2017 //
FIERCE BIOTECH
Amgen Submits Regulatory Applications In US & EU KYPROLIS Carfilzomib Label
14 Jul 2017 //
PR NEWSWIRE
Amgen`s battered Kyprolis nabs another survival win
14 Jul 2017 //
FIERCE PHARMA
Multiple myeloma patients to get NHS access to Amgen’s Kyprolis
15 Jun 2017 //
PHARMA TIMES
Kyprolis® (carfilzomib): Onyx Therapeutics, Inc. V.Teva Pharmaceuticals USA
20 Apr 2017 //
PATENT LITIGATION
